Dasatinib for Research

99% Pure SRC/BCR/ABL Inhibitor 100mg $263; 300mg $515 -- Bulk Also (Sponsored Link)
http://www.LCLabs.com/

 

MedlinePlus Drug Information: Dasatinib

Skip navigation ... Dasatinib comes as a tablet to take by mouth. ... Take dasatinib at around the same times every day. ... Take dasatinib exactly as directed. ... Continue to...
http://www.nlm.nih.gov/medlineplus/druginfo/medmaster/a607063.html

 

Sprycel (dasatinib)

Search: All NetDoctor ... Leukaemia Dasatinib monohydrate. ... Dasatinib works by interfering with the pathways that signal certain types of cancer cells to grow. ... Dasatinib...
http://www.netdoctor.co.uk/medicines/100005105.html

 

A new case with rare e6a2 BCR–ABL fusion transcript developing two new resistance mutations during imatinib mesylate, which were

... E-mail: [email protected] Top of page MORE ARTICLES LIKE THIS These links to content published by NPG are automatically generated RESEARCH Successful treatment of imatinib-resistant acute megakaryoblastic leukemia with e6a2...
http://dx.doi.org/10.1038/sj.leu.2404949

 

Patient Information Sheet: Dasatinib (marketed as Sprycel)

FDA Home Page | CDER Home Page | CDER Site Info | / Contact CDER | / What's New @ CDER / Search / Patient Information Sheet / Dasatinib (marketed as Sprycel) / PDF Print Version / This is a summary of the most important...
http://www.fda.gov/CDER/DRUG/InfoSheets/patient/dasatinibPIS.htm

 

LifeSciencesWorld : FDA Approves SPRYCEL(TM) (dasatinib) With Two Indications

... Dasatinib may cause fetal harm. ... Hypokalemia or hypomagnesemia should be corrected prior to dasatinib administration. Drug Interactions: Dasatinib is a CYP3A4 substrate....
http://www.lifesciencesworld.com/news/view/7587

 

Drug Development Technology - Dasatinib - Tyrosine Kinase Inhibitor for Chronic Myeloid Leukaemia (CML)

... Dasatinib, which will be marketed under the brand name Sprycel, was designated an orphan medicinal product at the end of 2005. ... "Preclinical experience with dasatinib suggests that it...
http://www.drugdevelopment-technology.com/projects/dasatinib/

 

Newly Approved Drug Therapies (903): Sprycel (dasatinib), Bristol-Myers Squibb

Description of Medical Areas / About the FDA Approved Listings / Drugs Approved by the FDA / Drug Name: Sprycel (dasatinib) ... Chen Z, Lee FY, Bhalla KN, Wu J Potent inhibition of platelet-derived growth factor-induced...
http://www.centerwatch.com/patient/drugs/dru903.html

 

Dasatinib, a small molecule protein tyrosine kinase inhibitor, inhibits T cell activation and proliferation.

Subscribe to daily bulletins of breaking research and drug development news ... Dasatinib, a small molecule protein tyrosine kinase inhibitor, inhibits T cell activation and proliferation. ......
http://www.leaddiscovery.co.uk/admin%20cancimmune/files/17962511.asp

 

Australian Prescriber Factor VIII inhibitor bypassing fraction

... Patients received 15-240 mg of dasatinib orally per day. ... Myelosuppression was a common adverse effect of dasatinib treatment. ... However, resistance to dasatinib has...
http://www.australianprescriber.com/latest_drugs/dasatinib

 

Genome Biology |homepage

Skip to main content / 4-Dec-2007 / home | comment | / reviews | / reports | / deposited research | ... Gene expression profiling was used to identify genes associated with sensitivity to the tyrosine kinase drug Dasatinib...
http://genomebiology.com/

 
1 | 2 | 3 | 4 | 5 | 6 | 7 | >